AE

Aevis Victoria SASWX Aevis Stock Report

Last reporting period 30 Jun, 2024

Updated 02 Dec, 2024

Last price

Market cap $B

1.268

Small

Exchange

XSWX - Six Swiss Exchange

AEVS.SW Stock Analysis

AE

Uncovered

Aevis Victoria SA is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

3/100

Low score

Market cap $B

1.268

Dividend yield

3.95 %

Shares outstanding

84.501 B

AEVIS VICTORIA SA is a holding company, which engages in healthcare, lifestyle, and infrastructure. The company is headquartered in Fribourg, Fribourg. The company invests in the healthcare, life sciences, hotels and lifestyles industries. Its activities are carried out in four segments. The Private Clinics segment includes Genolier Swiss Medical Network SA, a group of private clinics; Clinique Spontini SAS, a plastic surgery clinic; and IRJB Institut de Radiologie du Jura Bernois SA, which offers radiology services and ophthalmology consultancy; among others. The Other Healthcare and Wellness Activities segment includes Nescens SA, which operates better aging check-up centers; and AS Ambulance Services SA, specializing in transporting patients; among others. The Hotels segment includes Victoria-Jungfrau Collection AG, a hotel group. The Real Estate Revenue segment includes Swiss Healthcare Properties AG, a medical real estate company, and Patrimonium Healthcare Property Advisors AG, among others.

View Section: Eyestock Rating